1 January–31 December
Attributable to shareholders of PolyPeptide Group AG:
|
|
|
|
|
|
|
|
|
|
kEUR |
Share capital |
Share premium |
Translation reserve |
Treasury shares |
Other capital reserves |
Retained earnings |
Total |
|
|
|
|
|
|
|
|
|
|
Balance as at 1 January 2025 |
302 |
203,129 |
21,309 |
-8,398 |
425 |
140,477 |
357,244 |
|
|
|
|
|
|
|
|
|
|
Result for the year |
|
|
|
|
|
-21,169 |
-21,169 |
|
Remeasurement gain / (loss) on defined benefit plans, net of tax |
|
|
|
|
|
3,318 |
3,318 |
|
Currency exchange differences |
|
|
-333 |
|
|
|
-333 |
|
Total comprehensive income |
– |
– |
-333 |
– |
– |
-17,851 |
-18,184 |
|
|
|
|
|
|
|
|
|
|
Purchase of own shares |
|
|
|
-484 |
|
|
-484 |
|
Share-based payment |
|
|
|
|
2,022 |
|
2,022 |
|
Transfer of own shares |
|
|
|
2,416 |
-2,416 |
|
– |
|
Total transactions with owners |
– |
– |
– |
1,932 |
-394 |
– |
1,538 |
|
Balance as at 31 December 2025 |
302 |
203,129 |
20,976 |
-6,466 |
31 |
122,626 |
340,598 |
1 January–31 December
Attributable to shareholders of PolyPeptide Group AG:
|
|
|
|
|
|
|
|
|
|
kEUR |
Share capital |
Share premium |
Translation reserve |
Treasury shares |
Other capital reserves |
Retained earnings |
Total |
|
|
|
|
|
|
|
|
|
|
Balance as at 1 January 2024 |
302 |
203,129 |
21,832 |
-10,394 |
1,217 |
165,139 |
381,225 |
|
|
|
|
|
|
|
|
|
|
Result for the year |
|
|
|
|
|
-19,564 |
-19,564 |
|
Remeasurement gain / (loss) on defined benefit plans, net of tax |
|
|
|
|
|
-5,098 |
-5,098 |
|
Currency exchange differences |
|
|
-523 |
|
|
|
-523 |
|
Total comprehensive income |
– |
– |
-523 |
– |
– |
-24,662 |
-25,185 |
|
|
|
|
|
|
|
|
|
|
Share-based payment |
|
|
|
|
1,204 |
|
1,204 |
|
Transfer of own shares |
|
|
|
1,996 |
-1,996 |
|
– |
|
Total transactions with owners |
– |
– |
– |
1,996 |
-792 |
– |
1,204 |
|
Balance as at 31 December 2024 |
302 |
203,129 |
21,309 |
-8,398 |
425 |
140,477 |
357,244 |